Uptake, tissue distribution, and excretion of brevetoxin-3 administered to mice by intratracheal instillation
- PMID: 16760139
- PMCID: PMC2652734
- DOI: 10.1080/15287390500360091
Uptake, tissue distribution, and excretion of brevetoxin-3 administered to mice by intratracheal instillation
Abstract
Brevetoxins are a family of potent lipid-soluble neurotoxins produced by the dinoflagellate Karenia brevis, the organism responsible for Florida red tide. Brevetoxins aerosolized by surf and wind produce irritation of the eyes, nose, and throat in people on or near red tide-affected beaches. The effects of chronic exposures to brevetoxins on healthy and health-compromised individuals are not known. The purpose of this study was to investigate the pulmonary uptake, tissue distribution, and excretion of polyether brevetoxin-3 in mice, a rodent model for investigating the potential systemic adverse health effects associated with repeated brevetoxin inhalation. Male CBA/CaJ mice were administered [3H]brevetoxin-3 by intratracheal instillation. Groups of 3 mice were sacrificed immediately after instillation and at 0.5, 3, 6, 12, 24, 48, and 96 h postinstillation. Four additional mice were placed into metabolism cages for excreta collection up to 168 h postinstillation. Brevetoxin-3 distributed rapidly to all tissues, with the highest initial doses in the liver and gastrointestinal tract. Elimination half-times ranged from approximately 28 h for fat, heart, intestines, kidneys, liver, and muscle to approximately 90 h for brain and testes. The total dose to tissue ranged from 39 ng brevetoxin equivalents-h/g for testes to 406 ng brevetoxin equivalents-h/g for liver. Approximately 90% of excretion had occurred within 96 h, with 11 and 64% of the initial brevetoxin dose excreted in urine and feces, respectively. These results are consistent with earlier reports of rapid absorption and widespread tissue distribution of brevetoxins in rats.
Figures



Similar articles
-
Uptake, tissue distribution, and excretion of brevetoxin 3 administered to rats by intratracheal instillation.J Toxicol Environ Health A. 1999 Jul 9;57(5):345-55. doi: 10.1080/009841099157656. J Toxicol Environ Health A. 1999. PMID: 10405188
-
Tissue uptake, distribution and excretion of brevetoxin-3 after oral and intratracheal exposure in the freshwater turtle Trachemys scripta and the diamondback terrapin Malaclemys terrapin.Aquat Toxicol. 2017 Jun;187:29-37. doi: 10.1016/j.aquatox.2017.03.003. Epub 2017 Mar 7. Aquat Toxicol. 2017. PMID: 28363127
-
Inhalation toxicity of brevetoxin 3 in rats exposed for 5 days.J Toxicol Environ Health A. 2004 Sep 24;67(18):1443-56. doi: 10.1080/15287390490483809. J Toxicol Environ Health A. 2004. PMID: 15371231 Free PMC article.
-
Natural and derivative brevetoxins: historical background, multiplicity, and effects.Environ Health Perspect. 2005 May;113(5):621-5. doi: 10.1289/ehp.7499. Environ Health Perspect. 2005. PMID: 15866774 Free PMC article. Review.
-
Putative high-level toxicity pathways based on evidence of brevetoxin immunotoxicity in marine fauna.Aquat Toxicol. 2022 Nov;252:106298. doi: 10.1016/j.aquatox.2022.106298. Epub 2022 Sep 11. Aquat Toxicol. 2022. PMID: 36162204 Review.
Cited by
-
Review of Florida Red Tide and Human Health Effects.Harmful Algae. 2011 Jan 1;10(2):224-233. doi: 10.1016/j.hal.2010.08.006. Harmful Algae. 2011. PMID: 21218152 Free PMC article.
-
Effects of in vitro brevetoxin exposure on apoptosis and cellular metabolism in a leukemic T cell line (Jurkat).Mar Drugs. 2008 Jun 10;6(2):291-307. doi: 10.3390/md20080014. Mar Drugs. 2008. PMID: 18728729 Free PMC article.
-
Immune function in Trachemys scripta following exposure to a predominant brevetoxin congener, PbTx-3, as a model for potential health impacts for sea turtles naturally exposed to brevetoxins.Ecotoxicology. 2019 Nov;28(9):1085-1104. doi: 10.1007/s10646-019-02110-5. Epub 2019 Sep 26. Ecotoxicology. 2019. PMID: 31559558
-
The impact of APOE4 on neurological symptoms after exposure to K. brevis neurotoxin.Environ Toxicol Pharmacol. 2025 Jan;113:104621. doi: 10.1016/j.etap.2024.104621. Epub 2024 Dec 20. Environ Toxicol Pharmacol. 2025. PMID: 39710124
-
Placental transport of brevetoxin-3 in CD-1 mice.Toxicon. 2006 Dec 15;48(8):1018-26. doi: 10.1016/j.toxicon.2006.08.008. Epub 2006 Aug 18. Toxicon. 2006. PMID: 17011606 Free PMC article.
References
-
- Altshuler B, Pasternack B. Statistical measures of the lower limit of detection of a radioactivity counter. Health Phys. 1963;9:293–298. - PubMed
-
- Asai S, Krzanowski JJ, Anderson WH, Martin DF, Polson JB, Lockey RF, Bukantz SC, Szentivanyi A. Effects of toxin of red tide, Ptychodiscus brevis, on canine tracheal smooth muscle: A possible new asthma-triggering mechanism. J Allergy Clin Immunol. 1982;69:418–428. - PubMed
-
- Backer LC, Fleming LE, Rowan A, Cheng YS, Benson J, Pierce RH, Zaias J, Bean J, Bossart GD, Johnson D, Quimbo R, Baden DG. Recreational exposure to aerosolized brevetoxins during Florida red tide events. Harmful Algae. 2003;2:19–28. - PubMed
-
- Backer LC, Kirkpatrick B, Fleming LE, Cheng YC, Pierce R, Bean JA, Clark R, Johnson D, Wanner A, Tamer R, Zhou Y, Baden D. Occupational exposure to aerosolized brevetoxins during Florida red tide events: Effects on a healthy worker population. Environ Health Perspect. 2005;113(5):644–649. - PMC - PubMed
-
- Benson JM, Tischler DL, Baden DG. Uptake, tissue distribution, and excretion of PbTx-3 administered to rats by intratracheal instillation. J Toxicol Environ Health A. 1999;57:345–355. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources